Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Links shared publicly online about this topic.

1,069
total visits

Phadia's four new EliA autoimmune antibody assays receive FDA clearance

Today Phadia announced that it has received FDA 510 (K) clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome. The newly available EliA assays, anti-cardiolipin (aCL) IgG/IgM and anti-B2-glycoprotein 1 (anti-B2-GP1) IgG/IgM, have proven to be essential, sensitive, and specific markers to aid in the diagnosis of APS.

View full resource at news-medical.net

Tags: Stroke, Thrombotic Event, Disease and Condition, Pregnancy, FDA, Physician

Most Recently Shared on June 25, 2010 at 10:18 am By:

News-Medical.Net

Pregnancy News: Phadia's four new EliA autoimmune antibody assays receive FDA clearance: Today Phadia announced th... http://bit.ly/bdK5I7

2 years ago...

Retweet

Favorite

Also Shared By:

News-Medical.Net

Phadia Receives FDA 510(k) Clearance For Two New Autoimmune Assays

medicalnewstoday.com — “Phadia announced that it has received FDA 510(k) clearance for two new, CLIA Moderate Complexity, EliA autoimmune antibody assays. The new assays will provide physicians with additional tools need” View full resource at medicalnewstoday.com

Most Recently Shared on September 23, 2010 at 2:05 pm By:

MNT Gastrointestinal Health News

Phadia Receives FDA 510(k) Clearance For Two New Autoimmune Assays http://mnt.to/3Kcw #gastrointestinal

2 years ago...

Retweet

Favorite

Phadia Receives FDA Clearance for Autoimmune Assays | IVD Technology

ivdtechnology.com — “Phadia has received FDA 510K clearance for four new EliA autoimmune antibody assays. These new assays will provide physicians with additional tools needed to aid in the diagnosis of Antiphospholipid Syndrome (APS).” View full resource at ivdtechnology.com